Acrodermatitis Continua of Hallopeau in a 47-Year Old Filipino Female Treated with Topical Corticosteroids and Systemic Methotrexate
Abstract
Acrodermatitis continua of Hallopeau (ACH) is a rare pustular type of psoriasis with poorly understood pathophysiology characterized by chronic, sterile pustules on the fingers and toes with nail dystrophy and possible anonychia. No drug has thus far successfully achieved lasting remission. This case reports a 47-year old Filipino female who presented with multiple pustules on the fingers and toes of 32 years duration associated with pain, all unresponsive to oral antibiotics and analgesics. Gradual development of erosions, fissures, and scales were noted on all digits as well as intermittent join pain and swelling and nail disruption on the affected fingers with eventual anonychia. Radiography showed shortening of the distal phalanges on the first to third digits on both hands; and histopathology revealed psoriasiform dermatitis. The patient was started on twice daily clobetasol propionate ointment and oral methotrexate at 10mg/week for 3 weeks, subsequently increased to 15mg/week for 7 weeks, reaching a cumulative dose of 135mg, achieving resolution of most of the pustules with no new lesions noted. Erythema and scaling decreased while pain resolved. At 10 weeks of treatment, the patient presented with minimal pustules, erythema and dry residual scaling on all digits. ACH is a rare pustular type of psoriasis with epidemiologic data limited to anecdotal case reports. Furthermore, despite the lack of established management guidelines, several case reports have shown improvement with some available treatment options, including the ones employed in this case.
Copyright (c) 2024 Kirk Llew Quijote, Jen-Christina Lourdes Segovia, Lalaine Visitacion, Karla Phoebe Castaños

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
- Copyright and licensing: Authors retain copyright and grant the journal the right of first publication. The work is published under a Creative Commons Attribution-NonCommercial 4.0 International License that allows non-commercial sharing and reuse with appropriate acknowledgement of the authorship and initial publication in this journal.
- Non-exclusive distribution: Authors may enter into separate, additional, non-commercial contractual arrangements for the non-exclusive distribution of the published version of their work (e.g., posting in an institutional repository or inclusion in a book), with an acknowledgement of its initial publication in this journal.
- Editorial and publication rights: Authors grant the journal permission to rewrite, edit, modify, store and/or publish the submission, including abstracts, supplementary materials, and any necessary errata, in any medium or format, and in publicly available publications or databases.
- Originality and rights assurance: Authors warrant that the submission is original, that they hold the rights to the work, and that it does not infringe upon or violate the copyright or other rights of any third party.